Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Yajuan Ke
Dian Diagnostics Group Co Ltd
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
44
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Real-World Evidence-Based Study on Discontinuation of Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia
Number of pages: 27
Posted: 09 Jul 2025
Fang Cheng
,
Yu Wang
,
Yu Zhu
,
Yunfan Yang
,
Jianyu Weng
,
Na Xu
,
Jian Huang
,
Zhenfang Liu
,
Hongbo Ren
,
Huifang Zhao
,
Huanling Zhu
, Yajuan Ke,
Weiyan Wu
,
Xin Du
,
Qian Jiang
,
Yanli Zhang
and
Wei-Ming Li
Wuhan Union Hospital, Dian Diagnostics Group Co Ltd, Nanjing Medical University, Sichuan University, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Zhejiang University - Department of Hematology, Guangxi Medical University, The First People’s Hospital of Jingzhou, Zhengzhou University - Henan Cancer Hospital, Sichuan University, Dian Diagnostics Group Co Ltd, Dian Diagnostics Group Co Ltd, Peking University, Peking University, Zhengzhou University - Henan Cancer Hospital and Huazhong University of Science and Technology - Department of Hematology
Downloads
44
(1,133,231)
View PDF
Download
Abstract:
Chronic myeloid leukaemia, treatment-free remission, prediction model
Feedback